Global Inequalities In Pharmacovigilance: A Critical Review And Methodological Framework For Inclusive Pharmacoepidemiology
Post-marketing drug safety surveillance relies overwhelmingly on data from high-income countries (HICs), creating a critical evidentiary blind spot for global health. Although lowand middle-income countries (LMICs) represent over 80% of the world’s population, they contribute less than 1% of individual case safety repo...